The exact mechanism behind taste disturbances with GLP-1 medications is not fully understood, though several factors may contribute
Gastrointestinal effects are the most commonly reported for each, especially during dose escalation
As the patient population continues to expand, healthcare providers are prioritizing treatment options that support longterm glycemic control while addressing broader metabolic risks, strengthening the adoption of GLP1 receptor agonists and DPP4 inhibitors
The highest tested concentration 10,000 mgl 1 led to a 6log 10 reduction within just 10 min, and no bacterial recovery was observed
"There needs to be more gold-standard, randomized, controlled clinical trials to understand the true potential of berberine," says Dana Ellis Hunnes, PhD, MPH, RD, a UCLA Health senior clinical dietitian